Article

ACAAI 2011: Vitamin D and Asthma, Part 2

There are conflicting data regarding whether vitamin D deficiency is a risk factor for asthma. Observational studies have linked low vit D status with impaired lung capacity, increased airway hyperresponsiveness, corticosteroid unresponsiveness, relatively poor asthma control, and higher rates of asthma-related hospitalization.

There are conflicting data regarding whether vitamin D (vit D) deficiency is a risk factor for asthma. Observational studies have linked low vit D status with impaired lung capacity, increased airway hyperresponsiveness (AHR), corticosteroid unresponsiveness, relatively poor asthma control, and higher rates of asthma-related hospitalization.

The following studies that suggest that vit D deficiency is a risk factor for asthma:

  • The National Health and Nutrition Examination Survey (NHANES) III had two findings supporting an association for vit D deficiency as a risk factor for asthma. First, there was a strong relationship in adults between low serum levels of 25(OH)D and reduced lung function in a cross-sectional analysis of approximately 25,000 subjects. Also, more upper respiratory tract infections (URIs) were noted with lower 25(OH)D levels, regardless of season of year; this association was even stronger in subjects with asthma.
  • A RCT involving over 300 Japanese school children provided additional evidence for an association between vit D deficiency and asthma. Children who received vit D daily (1,200 IU) for 4 months had 42% fewer influenza B infections (p = 0.04). Also, children with a history of asthma who took vit D had a 6-fold reduction in asthma attacks.
  • Sutherland and colleagues examined 54 adult asthmatics and found that low vit D levels were associated with increased production of proinflammatory protein in blood. Adults with higher vit D levels had better lung function measures, improved AHR, and better response to corticosteroid in vitro.

These studies suggest vit D may not be as beneficial as initially believed:

  • A 3-month RCT of vit D supplementation in adults showed no difference in URI severity or incidence. Dr. Foggs noted that the mean 25(OH)D levels in the treatment arm were low (35 ng/mL). It was unclear from this study what level of supplemental vit D is adequate for optimal immune function.
  • In a study from Finland, children who received vit D supplements in the 1st year of life had a higher risk of developing asthma, atopy, & AR in adulthood.
  • A UK study noted high maternal plasma 25(OH)D levels during late pregnancy were associated with higher risk of eczema in children at 9 months of age.
  • Lastly, a Swedish study showed higher intake of vit D in 1st year of life was associated an increased risk of developing atopic dermatitis by age 6.

Dr. Foggs noted there are several gaps in our knowledge of vit D, including:

  • Do low vit D levels contribute to increasing asthma severity?
  • Do low vit D levels make steroids less effective?
  • Does vit D directly affect corticosteroid activity?
  • Does vit D supplementation help reverse corticosteroid resistance?

(Dr. Foggs was also elected vice president of the College at this meeting. Congratulations.)

Click here to read part 1 of Dr. Foggs's discussion on vitamin D and asthma.

Related Videos
Investigating Briquilimab’s Efficacy and Safety for CSU, with Thomas Casale, MD
What to Look Forward to at the American Academy of Dermatology Annual Meeting 2025
Kent Lam I Credit: Macon & Joan Brock Virigina Health Sciences at Old Dominion University
Improving Care for ISM With Better Diagnosis, Disease Characterization, with Thanai Pongdee, MD
John Barbieri, MD, MBA | Credit: Brigham and Women's Hospital
Robert Wood, MD I Credit: Johns Hopkins Medicine
Achieving Chronic Spontaneous and Inducible Urticaria Control With Barzolvolimab, with Martin Metz, MD
Scott Commins, MD, PhD I Credit: UNC School of Medicine
Optimizing ISM Treatment Beyond Approval, with Vito Sabato, MBBS
Updated Treatment Strategies for Pediatric Atopic Dermatitis in 2025, with Ama Alexis, MD
© 2025 MJH Life Sciences

All rights reserved.